Literature DB >> 17107660

LNA-modified oligonucleotides effectively drive intramolecular-stable hairpin to intermolecular-duplex state.

Harleen Kaur1, Jesper Wengel, Souvik Maiti.   

Abstract

Sequence-specific hybridization of antisense and antigene agent to the target nucleic acid is an important therapeutic strategy to modulate gene expression. However, efficiency of such agents falls due to inherent intramolecular-secondary-structures present in the target that pose competition to intermolecular hybridization by complementary antisense/antigene agent. Performance of these agents can be improved by employing structurally modified complementary oligonucleotides that efficiently hybridize to the target and force it to transit from an intramolecular-structured-state to an intermolecular-duplex state. In this study, the potential of variably substituted locked nucleic acid-modified oligonucleotides (8mer) to hybridize and disrupt highly stable, secondary structure of nucleic acid has been biophysically characterized and compared with the conventionally used unmodified DNA oligonucleotides. The target here is a stem-loop hairpin oligonucleotide-a structure commonly present in most structured-nucleic acids and known to exhibit an array of biological functions. Using fluorescence-based studies and EMSA we prove that LNA-modified oligonucleotides hybridize to the target hairpin with higher binding affinity even at lower concentration and subsequently, force it to assume a duplex conformation. LNA-modified oligonucleotides may thus, prove as potential therapeutic candidates to manipulate gene expression by disruption of biologically relevant nucleic acid secondary structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17107660     DOI: 10.1016/j.bbrc.2006.10.155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Regulation of alveolar septation by microRNA-489.

Authors:  Nelida Olave; Charitharth V Lal; Brian Halloran; Kusum Pandit; Alain C Cuna; Ona M Faye-Petersen; David R Kelly; Teodora Nicola; Panayiotis V Benos; Naftali Kaminski; Namasivayam Ambalavanan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-30       Impact factor: 5.464

Review 2.  Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders.

Authors:  Flavien Bizot; Adeline Vulin; Aurélie Goyenvalle
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

3.  Contributions of stacking, preorganization, and hydrogen bonding to the thermodynamic stability of duplexes between RNA and 2'-O-methyl RNA with locked nucleic acids.

Authors:  Elzbieta Kierzek; Anna Pasternak; Karol Pasternak; Zofia Gdaniec; Ilyas Yildirim; Douglas H Turner; Ryszard Kierzek
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

4.  Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.

Authors:  Keith T Gagnon; Hannah M Pendergraff; Glen F Deleavey; Eric E Swayze; Pierre Potier; John Randolph; Eric B Roesch; Jyoti Chattopadhyaya; Masad J Damha; C Frank Bennett; Christophe Montaillier; Marc Lemaitre; David R Corey
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

5.  Mapping the nicking efficiencies of nickase R.BbvCI for side-specific LNA-substituted substrates using rolling circle amplification.

Authors:  Hua Wei; Guojie Zhao; Tianyu Hu; Suming Tang; Jiquan Jiang; Bo Hu; Yifu Guan
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

Review 6.  The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.

Authors:  Philippine Aupy; Lucía Echevarría; Karima Relizani; Aurélie Goyenvalle
Journal:  Biomedicines       Date:  2017-12-22

7.  MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha.

Authors:  Amelia Freeman; Luhua Qiao; Nelida Olave; Gabriel Rezonzew; Samuel Gentle; Brian Halloran; Gloria S Pryhuber; Amit Gaggar; Trent E Tipple; Namasivayam Ambalavanan; Charitharth Vivek Lal
Journal:  Respir Res       Date:  2021-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.